Polianta Ltd’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-12,400
Closed -$1.18M 106
2018
Q3
$1.18M Buy
+12,400
New +$1.06M 0.59% 43
2018
Q2
Sell
-15,770
Closed -$1.09M 98
2018
Q1
$1.09M Sell
15,770
-4,930
-24% -$376K 0.33% 65
2017
Q4
$1.54M Buy
20,700
+5,800
+39% +$371K 0.5% 24
2017
Q3
$943K Hold
14,900
0.3% 73
2017
Q2
$951K Hold
14,900
0.4% 67
2017
Q1
$982K Hold
14,900
0.59% 62
2016
Q4
$1.02M Buy
+14,900
New +$1.07M 0.55% 59

Other funds holding ESRX

Polianta Ltd's ESRX Position: Q4 2018 in Review

Polianta Ltd sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 12,400 shares — an estimated $1.18M sold.

Polianta Ltd first reported a position in ESRX in Q4 2016 and held it in 7 quarters. The position peaked at $1.54M in Q4 2017. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • Polianta Ltd reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • Polianta Ltd sold 12,400 Express Scripts Holding Company shares in Q4 2018, an estimated $1.18M.
  • Polianta Ltd first reported a position in Express Scripts Holding Company in Q4 2016 and held it in 7 quarters.
  • Polianta Ltd's Express Scripts Holding Company position peaked at $1.54M in Q4 2017.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on Polianta Ltd's 13F filing for Q4 2018, filed 15 Jan 2019.